Comment from American Academy of Family Physicians
AnonymousSupportAdvocacy
Summary: The American Academy of Family Physicians (AAFP) supports the FDA's proposed robust evidentiary framework for flavored ENDS premarket applications, emphasizing the need to evaluate youth risk based on multiple factors including nicotine content and delivery characteristics. They urge the FDA to explicitly include disposable and "smart" vapes in this framework and to prioritize the prevention of youth initiation over potential adult cessation benefits.
On behalf of the American Academy of Family Physicians (AAFP), which represents more than 124,500 family physicians and medical students across the country, please see the attached comments in response to this draft guidance.